Valeant Pharmaceuticals was a multinational specialty pharmaceutical company based in Canada. It grew rapidly through a series of mergers and acquisitions under the leadership of J. Michael Pearson. The company was involved in a number of controversies surrounding drug price hikes and the use of a specialty pharmacy for the distribution of its drugs, which led to an investigation by the U.S. Securities and Exchange Commission and caused its stock price to plummet more than 90 percent from its peak while its debt surpassed $30 billion. Wall Street short-sellers exposed a scam that regulators overlook: how Big Pharma gouges patients in need of life-saving drugs.
For decades, HSBC, one of the world's largest banks, laundered hundreds of millions of dollars for Mexican drug cartels. Senator Elizabeth Warren, dogged journalists and prosecutors try to hold the bankers to account.
In Canada, maple syrup is worth more than oil. When $20 million of syrup goes missing, the trail leads back to an epic battle between cartels and the little guy.
Weaving together a tapestry of tales in real estate booms and busts, Stevens lays out how Donald Trump's business career transformed from epic failures into a consummate branding machine that propelled him into office.
From virtually the moment we're born, there's a story that's preached across cultures and continents. It's a familiar fairy tale, that finding one true love is the key to a fulfilled and happy life. As an adult, we're forced to reconcile the messaging on monogamy with one simple fact: humans are terrible at it. What do biology, human history and the promiscuity of bonobos reveal about monogamy? Experts and everyday couples weigh in on shifting cultural norms.
This episode looks at a group of black survivalists. British Buzzfeed correspondent Bim Adewunmi looks at an unusual group of doomsday preppers who don't fit the normal stereotype for that group. She interviews people of color who train themselves to prepare for disaster.
Wall Street short-sellers exposed a scam that regulators overlook: how Big Pharma gouges patients in need of life-saving drugs.